SKYE News and Press, Skye Bioscience Inc Com From 11/25/25

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like ...

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience PR Newswire Faruqi & Faruqi, LLP Securities Litigation Partner ...

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Skye Bioscience, Inc. (NASDAQ: SKYE) securities between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”). Skye is a clinical st...

2025-11-10 22:42:24 ET More on Skye Bioscience Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call Transcript Skye Bioscience, Inc. (SKYE) CBeyond Phase 2a Clinical Trial Topline Data Conference Call Transcript Skye Bioscience, Inc. (SKYE) Special Call - Slideshow ...

2025-11-10 22:41:31 ET Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call Transcript

2025-11-10 16:01:55 ET More on Skye Bioscience Skye Bioscience, Inc. (SKYE) CBeyond Phase 2a Clinical Trial Topline Data Conference Call Transcript Skye Bioscience, Inc. (SKYE) Special Call - Slideshow Skye Bioscience: Promising Nimacimab Data Supports Buy Rating ...

Topline nimacimab Phase 2a study data showed clinically meaningful weight loss in nimacimab/semaglutide combination cohort versus semaglutide alone after 26 weeks of treatment; the data demonstrated a clean neuropsychiatric safety profile and no increase in gastrointestinal adverse events. ...

2025-11-10 10:00:00 ET Major earnings expected after the bell on Monday include: Plug Power ( PLUG ) Occidental Petroleum Corporation ( OXY ) Beyond Meat ( BYND ) Inovio Pharmaceuticals ( INO ) BigBear.ai Holdings ( BBAI ) Read the full arti...

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...

2025-11-09 17:42:17 ET Skye Bioscience, Inc. (SKYE) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.05%. The average open to low on the day of earnings was -7.91%. The average open to ...